Navigation Links
Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Date:8/28/2007

une 2006, HGS announced that the U.S. government exercised its option under an existing contract to purchase 20,000 doses of ABthrax(TM) (raxibacumab) for the treatment of anthrax disease. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of hematologic and solid malignancies.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. For more information about Albuferon, please visit http://www.hgsi.com/products/albuferon.html. Health professionals or patients interested in Albuferon clinical trials or other studies involving HGS products may inquire via the "Contact Us" section of the Company's web site, http://www.hgsi.com/products/request.html, or by calling (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)...   Aratana Therapeutics, Inc . (NASDAQ: ... licensing, development and commercialization of innovative biopharmaceutical products for ... the Barclays Global Healthcare Conference to be ... Hotel in Miami , FL.  ... and Chief Executive Officer of Aratana Therapeutics, will provide ...
(Date:3/4/2015)... 2015  Results of the recent study, Results ... for Intra-Operative Positive Margin Detection , were presented as ... nd Annual Miami Breast Cancer Conference last week. ... Papa , MD, FACS, Professor of Surgery at the ... an analysis of MarginProbe,s efficiency and accuracy when used ...
(Date:3/4/2015)... 2015 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... overview at the 27th Annual ROTH Conference on March ... Laguna Niguel, California . To learn more about ... A live webcast of the presentation will be ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... Plan for Biomarker Study -, MONTVALE, N.J., ... ) today announced that it plans to,conduct a ... nicotinic alpha-7,partial agonist, on two biomarkers of schizophrenia, ... schizophrenia. The biomarker study,and additional formulation and manufacturing ...
... Developed Test in the U.S. for Detecting the ... Mosquito-Borne Infectious Disease, ... diagnostics company of Quest Diagnostics (NYSE: DGX ),today announced ... mosquito-borne chikungunya virus. Commercial availability of,the molecular polymerase chain reaction ...
Cached Medicine Technology:Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 2Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 3Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 4Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 2Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 3Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 4
(Date:3/4/2015)... March 05, 2015 The emergence ... landscape over the past decade. The pharmaceutical world ... drug delivery in the form of liposomes and ... drugs with more safety and efficiency. In ... perhaps rely greatly upon the enhanced permeability and ...
(Date:3/4/2015)... Las Vegas, NV (PRWEB) March 04, 2015 ... good as the fight that is the main event. For ... announced and that fight will be for the UFC Featherweight ... against the brash, often out-spoken native of Ireland, Conor “Notorious” ... the MGM Grand Garden Arena in Las Vegas, NV. , ...
(Date:3/4/2015)... Florida (PRWEB) March 04, 2015 Ultraman ... a 6.2 mile swim, 261.4 mile bike, and 52.4 ... a total time of 24:45:45. , "This race was ... to my wonderful team and sponsors for supporting me ... Ultraman Florida 2015 had a total of 40 select ...
(Date:3/4/2015)... Dr. Christopher Asandra, M.D., Founder and Chief Medical ... the FDA’s recent decision to issue a warning ... FDA’s conclusions are not supported by science, and that ... deficiency. , “The FDA appears to have developed a ... Dr. Asandra. “There is not nearly enough evidence to ...
(Date:3/4/2015)... TROY Healthcare Solutions will be introducing TROY Secure ... of security for prescriptions, in Houston, Texas on Wednesday, ... located at 6633 Travis Street from 7 AM to ... Healthcare Solutions will host a continental breakfast. Starting at ... each hour to introduce attendees to TROY Secure Print ...
Breaking Medicine News(10 mins):Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3
... National Football League (NFL) will give a $1 million ... Traumatic Encephalopathy (CSTE) at Boston University School of Medicine ... funds will be used to continue the Center,s ground-breaking ... in athletes, in particular football players. CSTE researchers have ...
... Minn. -- The growing number of Americans with cardiovascular ... of chest pain. In a study published in the ... reported that patients dismissed from the hospital with noncardiac ... highlight a need for more aggressive cardiovascular risk factor ...
... for inflammation , TUESDAY, April 20 (HealthDay News) -- ... have something to do with components of virgin olive ... study reports. , "These findings strengthen the relationship between ... most basic level of healthy effects derived from virgin ...
... ... , ... 20, 2010 -- As the debate around legalization intensifies from coast to coast, CNBC.com ... of business. "Marijuana & Money" thoroughly examines the current marketplace as well as ...
... ... $2500 so far in a weight loss challenge, benefiting City CURE’s Whiz Kids program. Dr. ... is to raise $3000. City CURE is a non-profit organization in Cincinnati whose goal is ... ...
... "I was ... her pancreatic cancer. But the Chicago woman refused to give up in her fight ... Hepatobiliary Diseases at Northwest Community Hospital in Arlington Heights, where the expertise of Dr. Malcolm ... ...
Cached Medicine News:Health News:NFL gives $1 million unrestricted gift to Boston University to study impact of brain injuries 2Health News:NFL gives $1 million unrestricted gift to Boston University to study impact of brain injuries 3Health News:Outcomes of patients dismissed from the hospital with non-cardiac chest pain 2Health News:CNBC.com Presents "Marijuana & Money" 2Health News:CNBC.com Presents "Marijuana & Money" 3Health News:CNBC.com Presents "Marijuana & Money" 4Health News:Dr. Sachin Patel Partners with City CURE to Raise $3000 in a Pound-4-Pound Challenge Benefiting Whiz Kids 2Health News:Given No Chance to Survive with Pancreatic Cancer, Chicago Woman Finds New Life at Northwest Community Hospital 2Health News:Given No Chance to Survive with Pancreatic Cancer, Chicago Woman Finds New Life at Northwest Community Hospital 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: